Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q418192> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Q418192 subject Q8297717.
- Q418192 subject Q8659716.
- Q418192 subject Q8695660.
- Q418192 subject Q8805811.
- Q418192 subject Q8844626.
- Q418192 abstract "Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL). It is a third-generation retinoid.".
- Q418192 atcPrefix "L01".
- Q418192 atcSuffix "XX25".
- Q418192 casNumber "153559-49-0".
- Q418192 chEBI "50859".
- Q418192 drugbank "DB00307".
- Q418192 fdaUniiCode "A61RXM4375".
- Q418192 iupacName "4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid".
- Q418192 pubchem "82146".
- Q418192 thumbnail Bexarotene2DACS.svg?width=300.
- Q418192 wikiPageWikiLink Q11081.
- Q418192 wikiPageWikiLink Q1138468.
- Q418192 wikiPageWikiLink Q128581.
- Q418192 wikiPageWikiLink Q130146.
- Q418192 wikiPageWikiLink Q1368197.
- Q418192 wikiPageWikiLink Q1467339.
- Q418192 wikiPageWikiLink Q14864419.
- Q418192 wikiPageWikiLink Q1527888.
- Q418192 wikiPageWikiLink Q16552.
- Q418192 wikiPageWikiLink Q17.
- Q418192 wikiPageWikiLink Q18225.
- Q418192 wikiPageWikiLink Q204711.
- Q418192 wikiPageWikiLink Q211544.
- Q418192 wikiPageWikiLink Q2838685.
- Q418192 wikiPageWikiLink Q30.
- Q418192 wikiPageWikiLink Q3100515.
- Q418192 wikiPageWikiLink Q3454518.
- Q418192 wikiPageWikiLink Q407883.
- Q418192 wikiPageWikiLink Q407927.
- Q418192 wikiPageWikiLink Q408524.
- Q418192 wikiPageWikiLink Q420418.
- Q418192 wikiPageWikiLink Q425517.
- Q418192 wikiPageWikiLink Q47912.
- Q418192 wikiPageWikiLink Q5196687.
- Q418192 wikiPageWikiLink Q604924.
- Q418192 wikiPageWikiLink Q6740853.
- Q418192 wikiPageWikiLink Q7417591.
- Q418192 wikiPageWikiLink Q762713.
- Q418192 wikiPageWikiLink Q8297717.
- Q418192 wikiPageWikiLink Q8659716.
- Q418192 wikiPageWikiLink Q8695660.
- Q418192 wikiPageWikiLink Q8805811.
- Q418192 wikiPageWikiLink Q8844626.
- Q418192 wikiPageWikiLink Q903384.
- Q418192 wikiPageWikiLink Q974135.
- Q418192 atcPrefix "L01".
- Q418192 atcSuffix "XX25".
- Q418192 casNumber "153559".
- Q418192 chebi "50859".
- Q418192 drugbank "DB00307".
- Q418192 iupacName "4".
- Q418192 pubchem "82146".
- Q418192 unii "A61RXM4375".
- Q418192 type ChemicalSubstance.
- Q418192 type Drug.
- Q418192 type ChemicalObject.
- Q418192 type Thing.
- Q418192 type Q8386.
- Q418192 comment "Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL). It is a third-generation retinoid.".
- Q418192 label "Bexarotene".
- Q418192 depiction Bexarotene2DACS.svg.